The Pick News

CLINICAL TRIAL TO TEST EFFECTIVENESS OF HEALTHY HEIGHT® ON CHILDREN UNDERGOING ADHD STIMULANT TREATMENT - The Pick Online Magazine

Written by Staff Writer | Jul 13, 2021 8:49:40 AM

Nutritional Growth Solutions Ltd. ASX:NGS),a global nutrition company that creates scientifically formulated and clinically proven supplements to support growth development in children, has signed an agreement for Schneider Children’s Medical Centre to clinically test the effectiveness of Healthy Height® on the height and weight of children treated with stimulant medications for ADHD (Attention Deficit Hyperactivity Syndrome).

Studies report that children treated with stimulants for ADHD may suffer attenuation in height gain both in the short and long term1, which is why an intervention to increase height gain is needed.

The randomised, double-blind, placebo-controlled clinical trial will be conducted by the Schneider Children’s Medical Centre, the world-renowned specialists in child health and nutrition, where Healthy Height® was created.

About 70-140 children under the age of 10 who are currently being treated for ADHD through prescribed stimulant medication will participate in the trial with half of them supplementing their diet with the Healthy Height® formula and the other half with a placebo product to determine if nutritional intervention with Healthy Height®, increases growth in children treating ADHD with stimulant medication.

Attention-deficit hyperactivity disorder (ADHD) is a common behavioural disorder for children. Stimulant use is greatest between 6 and 12 years of age, although use among adolescents is also increasing2. Systematic reviews indicate the community prevalence globally is between two and seven per cent, with an average of around five percent3.

Liron Fendell, CEO and Managing Director of NGS said,

“ADHD is a prevalent disorder globally with treatment’s adverse side effects including decreased appetite. In the U.S., insurance coverage decisions by commercial insurance and government payers are tied to medical necessity and discreet diagnoses. If the trial provides clear evidence that Healthy Height supports children with an ADHD diagnosis who have been prescribed meds achieve normal growth and counteract the negative effects of the drugs, we believe the payers will be more likely to cover Healthy Height alongside an ADHD diagnosis.”

Healthy Height® is already clinically proven to increase height and weight in short and lean children aged three to nine years old by 13.8% – 34% to their annual growth with no increase in Body Mass Index (BMI) over a one-year period – the only nutritional supplement in the world to able to make this claim.